Laboratory Evaluation of Pheochromocytoma and Paraganglioma
Open Access
- 1 December 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 60 (12), 1486-1499
- https://doi.org/10.1373/clinchem.2014.224832
Abstract
Background: Pheochromocytomas and paragangliomas (PPGLs) are potentially lethal yet usually surgically curable causes of endocrine hypertension; therefore, once clinical suspicion is aroused it is imperative that clinicians choose the most appropriate laboratory tests to identify the tumors. Content: Compelling evidence now indicates that initial screening for PPGLs should include measurements of plasma free metanephrines or urine fractionated metanephrines. LC-MS/MS offers numerous advantages over other analytical methods and is the method of choice when measurements include methoxytyramine, the O-methylated metabolite of dopamine. The plasma test offers advantages over the urine test, although it is rarely implemented correctly, rendering the urine test preferable for mainstream use. To ensure optimum diagnostic sensitivity for the plasma test, reference intervals must be established for blood samples collected after 30 min of supine rest and after an overnight fast when measurements include methoxytyramine. Similarly collected blood samples during screening, together with use of age-adjusted reference intervals, further minimize false-positive results. Extents and patterns of increases in plasma normetanephrine, metanephrine, and methoxytyramine can additionally help predict size and adrenal vs extraadrenal locations of tumors, as well as presence of metastases and underlying germline mutations of tumor susceptibility genes. Summary: Carried out correctly at specialist endocrine centers, collection of blood for measurements of plasma normetanephrine, metanephrine, and methoxytyramine not only provides high accuracy for diagnosis of PPGLs, but can also guide clinical decision-making about follow-up imaging strategies, genetic testing, and therapeutic options. At other centers, measurements of urine fractionated metanephrines will identify most PPGLs.Keywords
This publication has 75 references indexed in Scilit:
- Urinary free metanephrines and suitability of available quality control materialClinica Chimica Acta; International Journal of Clinical Chemistry, 2013
- Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolitesClinica Chimica Acta; International Journal of Clinical Chemistry, 2013
- Plasma-freevsdeconjugated metanephrines for diagnosis of phaeochromocytomaClinical Endocrinology, 2013
- PheochromocytomaClinical Chemistry, 2013
- Cardiovascular manifestations of phaeochromocytomaJournal Of Hypertension, 2011
- Measurements of Plasma Methoxytyramine, Normetanephrine, and Metanephrine as Discriminators of Different Hereditary Forms of PheochromocytomaClinical Chemistry, 2011
- Biochemically Silent Abdominal Paragangliomas in Patients with Mutations in theSuccinate Dehydrogenase Subunit BGeneJournal of Clinical Endocrinology & Metabolism, 2008
- Measurement of Urinary Metanephrines to Screen for Pheochromocytoma in an Unselected Hospital Referral PopulationClinical Chemistry, 2006
- The Laboratory Diagnosis of Adrenal Pheochromocytoma: The Mayo Clinic ExperienceJournal of Clinical Endocrinology & Metabolism, 2003
- Circulating and Urinary Catecholamines in PheochromocytomaNew England Journal of Medicine, 1979